Drug
Capecitabine(Aibin)
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_3
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
3(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Other(3)
Detailed Status
unknown3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 33 (100.0%)
Trials by Status
unknown3100%
Recent Activity
0 active trials
Showing 3 of 3
unknownphase_3
Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer
NCT02025036
unknownphase_3
The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy
NCT02604615
unknownphase_3
Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy
NCT02603159
Clinical Trials (3)
Showing 3 of 3 trials
NCT02025036Phase 3
Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer
NCT02604615Phase 3
The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy
NCT02603159Phase 3
Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3